Publication | Closed Access

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial

Gbg 44MedicineRandomised Phase 3Metronomic TherapyPathologyLapatinib Versus TrastuzumabCancer TreatmentOncologyRadiation OncologyChemotherapy